Posts Tagged ‘arvo’
ARVO Update: Powerful Protein Positioned Well for Human Study
If you or someone you’re close to has a retinal degenerative disease, you should know about the vision-saving promise of a protein called Rod-derived Cone Viability Factor (RdCVF). It was discovered by Foundation-funded clinician-researchers Drs. José Sahel and Thierry Léveillard, of Institut de la Vision in Paris. In fact, they won the Foundation’s Board of Director’s Award in 2005 for the finding. It was a monumental effort, namely because they screened thousands of proteins to come up with the gem.
ARVO Update: News on Gene Therapy Clinical Trials for RP and Choroideremia
I was very excited to learn here at ARVO that two early-stage gene therapy clinical trials – one for choroideremia taking place in the U.K., the other for autosomal recessive retinitis pigmentosa (arRP) caused by MERTK mutations underway in Saudi Arabia – are proceeding well thus far. It is important to keep in mind that safety is the primary focus in these Phase I studies.
Read more
ARVO Poster: Nanoparticle Treatment Slows Vision Loss in Mice
The Sunday morning poster session at ARVO included a Foundation-funded research effort from Oklahoma University (OU) in which Dr. Lily Wong and her colleagues used a nanoceria treatment to slow retinal degeneration in a mouse model of autosomal dominant retinitis pigmentosa (adRP).
Join Me (and 11,000 Other Eye Specialists) in Fort Lauderdale
I invite you to join me, this coming week, in sunny Fort Lauderdale, Florida – not for spring break, but for something even better. As is always the case this time of year, the Association for Research in Vision and Ophthalmology (ARVO) will host its international conference, providing thousands of eye professionals with the latest information on retinal research and technologies.









